With incidence of cardio-vascular disease growing amongst people on a worldwide scale, it is but natural for pharmaceutical companies to capitalize on the situation by releasing drugs that would combat the disease. To this effect, there are two companies running in the forefront of this race, namely Amgen Inc (NASDAQ:AMGN) which was the first to…